HUNGERFORD BRIAN (CFO) purchased 6.6% of their position (4K shares) of KIROMIC BIOPHARMA, INC. on the open market
Open‑market purchase worth $8.8K — a moderate purchase. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 8/21/2024ACC: 0001437749-24-027492
Officer· CFO
Since Oct 2023
+4K
Net shares
Net buyer
$8.8K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
4K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+258.00
Price / share
$2.25
Trade value
$580.50
% of position
0.4%
8/19/2024
60.93K→61.19K
Common Stock
Direct
Shares
+3.74K
Price / share
$2.20
Trade value
$8.22K
% of position
6.1%
8/20/2024
61.19K→64.93K
Total
Net shares
+4K
Net value
$8.80K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/19/2024 | P · Purchase | +258.00 | $2.25 | $580.50 | 0.4% | 60.93K | 61.19K |
| Common Stock Direct | 8/20/2024 | P · Purchase | +3.74K | $2.20 | $8.22K | 6.1% | 61.19K | 64.93K |
| Total | +4K | $8.80K | ||||||
Derivative Transactions0
No derivative transactions reported